The Scotland and Newcastle epidemiological study of Hodgkin’s disease: impact of histopathological review and EBV status on incidence estimates
暂无分享,去创建一个
G. M. Taylor | F. Alexander | B. Angus | R. Jarrett | G. Taylor | P. Taylor | J. Freeland | F. Alexander | A. Krajewski
[1] G. M. Taylor,et al. An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD): Evidence for a specific association with EBV+ve HD in young adults , 2003, International journal of cancer.
[2] E. Jaffe. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues , 2003 .
[3] F. Alexander,et al. Hodgkin lymphoma and Epstein‐Barr virus (EBV): No evidence to support hit‐and‐run mechanism in cases classified as non‐EBV‐associated , 2003, International journal of cancer.
[4] R. Jarrett. Viruses and Hodgkin's lymphoma. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] J. Whelan,et al. A systematic review of the role of pulmonary irradiation in the management of primary bone tumours. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] S. Glaser,et al. Expert review of the diagnosis and histologic classification of Hodgkin disease in a population‐based cancer registry , 2001, Cancer.
[7] G. M. Taylor,et al. Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve). , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[8] S. Glaser,et al. Epstein–Barr virus and survival after Hodgkin disease in a population‐based series of women , 2001, Cancer.
[9] V. Diehl,et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. , 2000, Blood.
[10] L. Weiss. Epstein-Barr virus and hodgkin’s disease , 2000, Current oncology reports.
[11] G. M. Taylor,et al. Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents , 2000, British Journal of Cancer.
[12] V. Diehl,et al. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] D. Wright,et al. Epstein–Barr virus and Hodgkin’s disease: further evidence for the three disease hypothesis , 1998, Leukemia.
[14] R. Jarrett,et al. Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin's disease. , 1998, British Journal of Cancer.
[15] P. Isaacson,et al. Follicular Hodgkin's disease. , 1995, The American journal of surgical pathology.
[16] H Stein,et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.
[17] S. Poppema,et al. Epstein‐barr virus positivity in hodgkin's disease does not correlate with an hla a2‐negative phenotype , 1994, Cancer.
[18] D. Jones,et al. Association of Epstein-Barr virus with pediatric Hodgkin's disease. , 1993, The American journal of pathology.
[19] K. Hübner,et al. Classification of Hodgkin's disease biopsies by a panel of four histopathologists. Report of 1,140 patients from the German National Trial. , 1993, Leukemia & lymphoma.
[20] K. Hübner,et al. Histopathological classification of Hodgkin's lymphomas. Results from the reference pathology of the German Hodgkin Trial. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] S. Hamilton-Dutoit,et al. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease , 1991, The Lancet.
[22] L. Specht,et al. Changes over the course of time in histological subclassification of Hodgkin's disease in Denmark. , 1991, Danish medical bulletin.
[23] S. Glaser,et al. Time trends in Hodgkin's disease incidence: The role of diagnostic accuracy , 1990, Cancer.
[24] D. Cunningham,et al. Use of Leu M1 and antiepithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin's disease. , 1986, Journal of clinical pathology.
[25] A. Bartolucci,et al. Results of a uniform histopathologic review system of lymphoma cases a ten‐year study from the southeastern cancer study group , 1983, Cancer.
[26] C. Holman,et al. Inter‐observer variation in the histopathological reporting of Hodgkin's disease: an analysis of diagnostic subcomponents using kappa statistics , 1983, Histopathology.
[27] T. Miller,et al. Mistaken clinical and pathologic diagnoses of Hodgkin's disease: a Southwest oncology group study. , 1982, Cancer treatment reports.
[28] Woodruff Rd. Reviewing histologic diagnosis of lymphoma: comparison of original and review diagnoses in 269 cases. , 1981 .
[29] Giffen Jw. Hodgkin's disease , 1980, Bone Marrow Transplantation.
[30] J. Holý,et al. [Epidemiology of Hodgkin's disease]. , 1977, Ceskoslovenska pediatrie.
[31] C. Coltman,et al. Histopathologic review of lymphoma cases from the southwest oncology group , 1977, Cancer.
[32] K. Franssila,et al. Epidemiology and histopathology of Hodgkin's disease in Finland , 1977, Cancer.
[33] M. Myers,et al. International comparability and reproducibility in histologic subclassification of Hodgkin's disease. , 1973, Journal of the National Cancer Institute.
[34] R. Factor,et al. Observer disagreement in the classification and histology of Hodgkin's disease. , 1970, Journal of the National Cancer Institute.
[35] R. Lukes,et al. The pathology and nomenclature of Hodgkin's disease. , 1966, Cancer research.
[36] K. Rajewsky,et al. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease. , 1998, Annual review of immunology.
[37] Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17-24 June 1997. , 1997, IARC monographs on the evaluation of carcinogenic risks to humans.
[38] A. Jarrett,et al. Epidemiology of EBV and Hodgkin's lymphoma. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.
[39] E. Alba,et al. Alternating chemotherapy for small-cell lung cancer. A twelve-week schedule of six drugs. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.
[40] G. Roos,et al. Hodgkin's disease in northern Sweden 1971-1981. I. A histopathological reevaluation of 223 cases. , 1991, Acta oncologica.
[41] K. Maclennan,et al. The Clinical and Prognostic Relevance of Histopathologic Classification in Hodgkin’s Disease , 1989 .
[42] R. Hartsock,et al. Pathology Panel for Lymphoma Clinical Studies: a comprehensive analysis of cases accumulated since its inception. , 1982, Journal of the National Cancer Institute.
[43] R. Woodruff. Reviewing histologic diagnosis of lymphoma: comparison of original and review diagnoses in 269 cases. , 1981, Archives of pathology & laboratory medicine.
[44] B. Armstrong,et al. THE RYE CLASSIFICATION OF A POPULATION BASED SERIES OF HODGKIN'S DISEASE PATIENTS IN WESTERN AUSTRALIA , 1981, Pathology.